1. Home
  2. FDP vs RARE Comparison

FDP vs RARE Comparison

Compare FDP & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresh Del Monte Produce Inc.

FDP

Fresh Del Monte Produce Inc.

HOLD

Current Price

$39.80

Market Cap

2.1B

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$20.01

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FDP
RARE
Founded
1886
2010
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
FDP
RARE
Price
$39.80
$20.01
Analyst Decision
Strong Buy
Analyst Count
0
18
Target Price
N/A
$61.22
AVG Volume (30 Days)
213.0K
1.6M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
2.97%
N/A
EPS Growth
N/A
7.31
EPS
1.88
N/A
Revenue
$4,322,300,000.00
$673,000,000.00
Revenue This Year
N/A
$13.40
Revenue Next Year
$3.75
$42.83
P/E Ratio
$21.47
N/A
Revenue Growth
0.98
20.13
52 Week Low
$29.00
$18.41
52 Week High
$43.58
$40.17

Technical Indicators

Market Signals
Indicator
FDP
RARE
Relative Strength Index (RSI) 38.95 34.41
Support Level $34.76 $19.61
Resistance Level $40.75 $23.44
Average True Range (ATR) 1.02 0.79
MACD -0.39 -0.12
Stochastic Oscillator 5.07 3.14

Price Performance

Historical Comparison
FDP
RARE

About FDP Fresh Del Monte Produce Inc.

Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: